Importance of immune response genes in hemophilia A

Autor: Josiane Bazzo de Alencar, Luciana Conci Macedo, Morgana Ferreira de Barros, Camila Rodrigues, Renata Campos Cadide, Ana Maria Sell, Jeane Eliete Laguila Visentainer

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 4, Pp 280-286 (2013)

Hemophilia A is a disease caused by a deficiency of coagulation factor VIII resulting from genetic inheritance linked to chromosome X. One treatment option is the administration of plasma or recombinant FVIII. However, some patients develop inhibitor

Externí odkaz: https://doaj.org/article/a1822fdeb9404e2b9ff712036c31f8f0

PERFIL EPIDEMIOLÓGICO DE DOADORES DE SANGUE INAPTOS SOROLÓGICOS E AUTOEXCLUÍDOS NO CENTRO DE HEMATOLOGIA E HEMOTERAPIA DO PARANÁ – HEMEPAR

Autor: Morgana Ferreira De Barros, Nicole Alves da Hora, Keyla Caroline Ost, Michele Ana Flores Chaves

Publikováno v: Anais do(a) Anais do 8° COSIMP – Congresso de Ciências Farmacêuticas do Mercosul - 8° Simpósio em Ciências e Tecnologia de Alimentos do Mercosul – XII CISDEM – Fórum da Cátedra Iberoamericana-Suissa de Desarrollo de Medicamentos.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5fe073ab482d51663cebecf2cf8c409f
https://doi.org/10.29327/127986.8-2

Importance of immune response genes in hemophilia A

Autor: Morgana Ferreira de Barros, Camila Rodrigues, Jeane Eliete Laguila Visentainer, Josiane Bazzo de Alencar, Luciana Conci Macedo, Renata Campos Cadidé, Ana Maria Sell

Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Volume: 35, Issue: 4, Pages: 280-286, Published: 2013
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 4, Pp 280-286 (2013)
Revista Brasileira de Hematologia e Hemoterapia v.35 n.4 2013
Revista brasileira de hematologia e hemoterapia
Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
Revista Brasileira de Hematologia e Hemoterapia

Hemophilia A is a disease caused by a deficiency of coagulation factor VIII resulting from genetic inheritance linked to chromosome X. One treatment option is the administration of plasma or recombinant FVIII. However, some patients develop inhibitor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32364ff4f9e0556f8dc159535cef953b
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842013000400280&lng=en&tlng=en

163-P: Influence of Class I and II HLA Alleles on Inhibitor Development in Haemophilia A Patients from the South of Brazil

Autor: Jeane Eliete Laguila Visentainer, Morgana Ferreira de Barros, Marco Antônio Braga, Juliana Curi Martinichen Herrero, Júlio Machado, Cinthia B. Pelissari, Loide Souza Hirle, Ana Maria Sell, Sandra de Souza Schiller, Fabiano Cavalcante de Melo

Publikováno v: Human Immunology. 71:S118

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19ca2e94518aba20f9f7c71370f31135
https://doi.org/10.1016/j.humimm.2010.06.217